Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

Recruiting Observational Study
Geographic Atrophy From Age-related Macular Degeneration
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 – 90
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
University of Utah · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate changes in retinal sensitivity over time in patients with geographic atrophy due to age related macular degeneration who are receiving pegcetacoplan as part of routine clinical care. The study aims to determine whether lesion tailored fundus-controlled perimetry can reliably measure functional changes near areas of atrophy and whether this testin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 65-90 years. * Geographic Atrophy (GA) secondary to dry Age-related Macular Degeneration (AMD) in at least one eye with the following criteria: * GA lesion size between 1 and 15 mm² (≈ 0.4 to 6 disc areas) * GA borders must be at least 500 μm from the edge of the 30° …
Contacts

Jenny Mireles

+1

jenny.mireles@utah.edu

CONTACT

Ray Nelson

+1

ray.nelson@hsc.utah.edu

CONTACT